HappeningToo topic
Denosumab reports
Browse community reports connected to Denosumab. These reports can show that other people are describing similar experiences, but they do not prove that Denosumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
36 problems
Abdominal Discomfort while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and abdominal discomfort appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and abdominal pain upper appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and abdominal pain appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and alopecia appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and anxiety appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and back pain appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and constipation appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and cough appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and decreased appetite appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and dehydration appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and diarrhea appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and dizziness appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and dry skin appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and fatigue appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and feeling abnormal appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and headache appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and hives appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and hot flush appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Influenza Like Illness while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and influenza like illness appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and insomnia appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and itching appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and malaise appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and muscle spasms appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and muscular weakness appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and myalgia appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and nausea appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Neck Pain while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and neck pain appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and pain appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and rash appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and shortness of breath appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and skin redness appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and tingling or pins and needles appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and vomiting appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and weakness appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and weight decreased appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Denosumab
FDA FAERS contains adverse-event reports in which Denosumab and weight increased appear together. This does not establish that Denosumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →